Ionis Pharmaceuticals is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.


Updates from The Motley Fool

Latest updates on Ionis Pharmaceuticals from Fool.com.  The Fool has written over 300 articles on Ionis Pharmaceuticals.


Stock Performance

View Interactive IONS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Ionis Pharmaceuticals.
Current Price: $46.50
Prev Close: $45.13
Open: $45.37
Bid: $46.37
Ask: $46.46
Day's Range: $44.72 - $46.45
52wk Range: $39.07 - $65.51
Volume: 225,435
Avg Vol 1,178,439
Market Cap: $6B
P/E (ttm): -167.15
EPS (ttm): -$0.27
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Ionis Pharmaceuticals.
CAPS Rating 4 out of 5
 
831 Outperform
38 Underperform
CAPS All Stars
 
165 Outperform
13 Underperform

How do you think Ionis Pharmaceuticals will perform against the market?



You pick for Ionis Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Ionis Pharmaceuticals.

Ionis Pharmaceuticals is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers